Ventracor Limited Investor Update March 2007
We are pleased and proud that the VentrAssist is an Australian success story that has improved the lives of almost 100 patients world-wide. The VentrAssist is still the only centrifugal LVAD and the only third generation LVAD in clinical trials in the USA. There is more world-wide clinical experience with the VentrAssist than all centrifugal LVADs from all competitors, combined.